Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis
Article in Frontiers in Oncology (February 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors
Article in Frontiers in Immunology (October 2022)
Bevacizumab/pembrolizumab/pemetrexed
Article in Reactions Weekly (January 2022)